Structural analysis and binding sites of inhibitors targeting the CD47/SIRPα interaction in anticancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural analysis and binding sites of inhibitors targeting the CD47/SIRPα interaction in anticancer therapy

Published:2021 Issue: Volume:19 Page:5494-5503
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Huang Bo,Bai Zhaoshi,Ye Xinyue,Zhou Chenyu,Xie Xiaolin,Zhong Yuejiao,Lin Kejiang,Ma Lingman

Funder

China Postdoctoral Science Foundation

Jiangsu Cancer Hospital

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference75 articles.

1. Current situation and future usage of anticancer drug databases;Wang;Apoptosis,2016

2. Cancer immunotherapy;Couzin-Frankel;Science,2013

3. Delivery technologies for cancer immunotherapy;Riley;Nat Rev Drug Discov,2019

4. IL-2: the first effective immunotherapy for human cancer;Rosenberg;J Immunol,2014

5. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat Rev Immunol,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment;Journal of Pharmaceutical Analysis;2024-09

3. Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1;mAbs;2024-06-07

4. The biological roles of CD47 in ovarian cancer progression;Cancer Immunology, Immunotherapy;2024-06-04

5. Development of small molecule drugs targeting immune checkpoints;Cancer Biology & Medicine;2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3